Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma
Clinical trial NCT03173430 · TERMINATED
Trial details
- NCT number
- NCT03173430
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-27
- Primary completion
- 2019-01-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.